Gilead Sciences reports strong Q2 2025 results, raises full-year guidance, and sees its stock surge to a 7-year high amid optimism about its strategy and pipeline momentum.
Israel approves Gaza occupation plan despite military concerns and Palestinian condemnation.
Wendy's lowers guidance amid revenue decline, but focuses on global expansion and shareholder returns.
Gilead Sciences reports strong Q2 2025 results, raises full-year guidance, and sees its stock surge to a 7-year high amid optimism about its strategy and pipeline momentum.
Israel approves Gaza occupation plan despite military concerns and Palestinian condemnation.
Wendy's lowers guidance amid revenue decline, but focuses on global expansion and shareholder returns.